CoChat

Telemedicine in dermatology: a randomised controlled trial

Open access
Bowns, I, Collins, K, Walters, S, McDonagh, A · 2006 · Health Technology Assessment

The DOI matches its Crossref record; 90 of the 97 references it cites were found in a registry or an index; 1 of the 25 sources its claims cite were checked for support.

Abstract

OBJECTIVES: To compare the clinical equivalence, patient and clinician opinion of store-and-forward (SF) teledermatology with conventional face-to-face consultation in setting a management plan for new, adult outpatient referrals. To assess the equivalence of digital photography and dermoscopy with conventional face-to-face consultation in the management of suspected cases of malignant melanoma or squamous cell carcinoma. DESIGN: For the SF teledermatology aspect of the study, a prospective randomised controlled trial was carried out. SETTING: Eight general practices and a hospital dermatology department in Sheffield, England. PARTICIPANTS: For the SF teledermatology part of the study, adults (aged 16 years and over) requiring a new (not seen by a hospital dermatologist within the past year) consultant opinion. For the digital photography element of the study, adults (aged 16 years and over) requiring a consultant opinion due to suspicion of malignant melanoma or squamous cell carcinoma. INTERVENTIONS: Patients in the telemedicine intervention group were referred to the consultant, and managed as far as possible using one or more digital still images and a structured, electronic referral and reply. The control group was managed by conventional hospital outpatient consultation. Patients referred to the 2-week wait clinic were invited to have a series of digital photographs, with and without dermoscopy, immediately before their face-to-face consultation. A second consultant viewed these and outlined a diagnosis and management plan which was compared with the actual management. Both were compared with the definitive diagnosis (either the final clinical or histological diagnosis, where undertaken). MAIN OUTCOME MEASURE: The concordance between the consultant who had managed the case and an independent consultant who gave a second face-to-face opinion. RESULTS: A total of 208 patients were recruited. There was also a greater loss of control cases (26%) than intervention cases (17%). A statistically significant difference in ages between the two groups completing the study (mean age of intervention group 43.6 years, control group 49.7 years, p = 0.039) indicates that this may have introduced a bias between the two groups. A further possible source of bias is the delay (mean difference of 54 days, p = 0.0001) between the SF opinion and the second opinion in the SF group, whereas control patients usually received their second opinion on the same day as their outpatient appointment. In 55% (51/92) of telemedicine cases and 78% (57/73) of control cases, the diagnosis concurred, with the second opinion. In 55% (51/92) of telemedicine cases and 84% (61/73) of control cases, the management plan concurred with the second opinion. Of the 92 telemedicine cases, 53 were judged also to require a face-to-face consultation, mainly to establish a diagnosis and treatment plan. With the digital photography for suspected skin cancer aspect of the study, it was found that an unexpectedly high proportion (33%, 85/256) of referrals proved to have a malignancy or a severely dysplastic lesion, with almost 22% having a malignant melanoma or squamous cell carcinoma, possibly reflecting the rise in incidence of skin cancers reported elsewhere. When both standard and dermoscopic images were employed, diagnostic concordance was modest (68%). The approach was highly sensitive (98%, 95% CI: 92 to 99%), at the expense of specificity (43%, 95% CI: 36 to 51%). Overall, 30% of cases would not have needed to be seen face-to-face, though two squamous cell carcinomas would have been missed (a number-needed-to-harm of 153). If the highest level of clinician confidence had been applied, no cancers would have been missed, but only 20% of patients would have avoided an outpatient appointment. CONCLUSIONS: In view of the difficulties in recruitment and the potential biases introduced by selective loss of patients and the delay in obtaining a valid second opinion in the study group, no valid conclusions can be drawn regarding the clinical performance of this model of SF telemedicine. With regard to digital photography in suspected skin cancer, it is unlikely that this approach can dramatically reduce the need for conventional clinical consultations, whilst still maintaining clinical safety. Additional research on the assessment of diagnostic and management agreement between clinicians would be valuable in this and other fields of research.

Overview

CoChat Summary

TL;DR

In a Sheffield randomised trial, store-and-forward teledermatology could not be validly compared with face-to-face care because recruitment failed and biases emerged; observed diagnostic and management concordance was lower for telemedicine. In a linked digital photography study of suspected skin cancer, sensitivity was high but specificity low, with 30% potentially avoiding face-to-face review but two squamous cell carcinomas missed.

Key findings

  • Store-and-forward teledermatology: diagnosis concurred with a second face-to-face opinion in 55% (51/92) of telemedicine cases vs 78% (57/73) of control cases (difference -23%, 95% CI -36 to -8; p = 0.002); management concurred in 55% (51/92) vs 84% (61/73) (difference -28%, 95% CI -40 to -14; p = 0.0001).
  • Of 92 telemedicine cases, 53 (58%, 95% CI 47 to 67%) were judged also to require a face-to-face consultation, mainly to establish diagnosis and treatment plan.
  • Digital photography for suspected skin cancer: 33% (85/256) had a malignancy or severely dysplastic lesion, with almost 22% having malignant melanoma or squamous cell carcinoma; diagnostic concordance was 68%, sensitivity 98% (95% CI 92 to 99%), specificity 43% (95% CI 36 to 51%).
  • Overall, 30% of digital photography cases would not have needed face-to-face review, but two squamous cell carcinomas would have been missed (number-needed-to-harm 153); using the highest clinician confidence, no cancers would have been missed but only 20% would have avoided an outpatient appointment.

Methods

  • Store-and-forward component: prospective randomised controlled trial in eight general practices and a hospital dermatology department in Sheffield, England; adults aged 16+ requiring a new consultant opinion were randomised to telemedicine (digital still images plus structured electronic referral/reply) or conventional hospital outpatient consultation.
  • Primary outcome: concordance between the managing consultant and an independent consultant who gave a second face-to-face opinion; analyses used intention-to-treat and per-protocol approaches, with equivalence assessed via confidence intervals.
  • Digital photography component: adults aged 16+ referred to the 2-week wait/target clinic for suspected malignant melanoma or squamous cell carcinoma had standard and dermoscopic photographs immediately before face-to-face consultation; a second consultant’s diagnosis and management plan were compared with actual management and the definitive clinical or histological diagnosis.

Limitations

  • Stated: recruitment failed to reach the target of 446 per group; only 208 patients were recruited, with greater loss of control cases (26%) than intervention cases (17%) and a significant age difference between completers (mean 43.6 vs 49.7 years, p = 0.039).
  • Stated: there was a mean 54-day delay (p = 0.0001) between the store-and-forward opinion and the second opinion in the intervention group, whereas control patients usually received their second opinion the same day; the authors conclude no valid conclusions can be drawn about clinical performance of this store-and-forward model.
  • Stated/evident: economic data collection was poor, preventing direct cost comparison; the digital photography study may have had recruitment bias toward higher-risk patients, and the authors note that only 30% would avoid face-to-face review while two squamous cell carcinomas would be missed.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.3310/hta10430

Cites

90 of 90 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

FIGURE 1 Numbers of patients recruited by participating practices (A-H)
FIGURE 1 Numbers of patients recruited by participating practices (A-H)From the PDF
FIGURE 2 CONSORT flowchart
FIGURE 2 CONSORT flowchartFrom the PDF
FIGURE 3 Equivalence of diagnostic and management outcomes
FIGURE 3 Equivalence of diagnostic and management outcomesFrom the PDF

Verification

Claims the paper makes

1 Valid · 0 Not valid · 10 Not checked · 14 Own results and interpretations

20 more claims

Create a free account to see all 25 claims and every source verdict.

See all claims — free account

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

5 of 8 · the rest aren’t loaded

3 more findings

Create a free account to see every finding of this check.

See all findings — free account

Citations

Cites

Research works printed but not linked: 3

  1. [17]17. Kim YS. Telemedicine in the USA with focus on clinical applications and issues. Yonsei Med J 2004; 45 :761-75.
  2. [15]15. physician perceptions and diagnostic agreement. Arch Dermatol 1998; 134 :471-6.
  3. [46]46. Taylor P , Goldsmith P , Murray K, Harris D, Barkley A, et al . Evaluating a telemedicine system to assist in the management of dermatology referrals. Br J Dermatol 2001; 144 :328-33.

Cited by

See all 109

Metadata

Authors
Bowns, I., Collins, K., Walters, S., & McDonagh, A.
Affiliations
  • University of Sheffield (GB)
  • Royal Hallamshire Hospital (GB)
Venue
Health Technology Assessment
Published
2006-11
Volume
10
Issue
43
Pages
iii-iv, ix
ISSN
  • 1366-5278 (ISSN-L)
  • 2046-4924
OpenAlex
W2141631049
Cited by
109
References
97
Citations by year
2026: 2 · 2025: 2 · 2024: 1 · 2023: 3 · 2022: 3 · 2021: 2 · 2020: 4 · 2019: 1 · 2018: 9 · 2017: 5 · 2016: 10 · 2015: 10 · 2014: 10 · 2013: 7 · 2012: 3
FWCI
6.00
Type
journal article
Language
en
Open access
Locations
  • Health Technology Assessment (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • SHURA (Sheffield Hallam University Research Archive) (Sheffield Hallam University) (submittedVersion)
Funders
Health Technology Assessment programme (96/02/26)
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Telemedicine and Telehealth Implementation
  • Health Sciences › Medicine › Oncology › Cutaneous Melanoma Detection and Management
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Healthcare Systems and Technology
Keywords
teledermatology, store-and-forward telemedicine, digital photography, dermoscopy, melanoma, squamous cell carcinoma, second opinion, outpatient referral, clinical equivalence, patient satisfaction, provider satisfaction, diagnostic agreement, skin cancer diagnosis, loss to follow-up
MeSH terms
Adolescent, Adult, Aged, Attitude of Health Personnel, Carcinoma, Squamous Cell, Dermatology, England, Family Practice, Female, Hospital Departments, Humans, Male, Melanoma, Middle Aged, Patient Acceptance of Health Care, Photography, Skin Neoplasms, State Medicine, Outcome Assessment, Health Care, Remote Consultation, Videoconferencing

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-09-26 (prompt extract-v2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.